Profit Crushed, Layoffs and Restructuring Follow: What WACKER Chemie’s 2025 Performance Reveals
In 2025, WACKER Chemie faced a sudden and severe downturn. The once-flagship German chemical company saw sales decline and profits collapse, triggering a chain reaction of layoffs and asset restructuring.
2025 Performance: From Profit to Loss
According to WACKER’s preliminary results:
-
EBITDA for 2025 was only €430 million, a 42% drop from €744 million in the previous year.
-
Full-year sales fell 4% to €5.49 billion, nearly reaching the bottom of the industry downturn.
-
Net profit plunged from a €260 million profit in 2024 to an €800 million loss, a historical low. Approximately €600 million of this came from asset impairments, write-downs, and operational deterioration.
These figures indicate that WACKER’s situation is not merely “lower profits” but “significant losses.” Price fluctuations, reduced capacity utilization, negative currency effects, and high energy costs collectively eroded the company’s profitability.
Structural Adjustments: From “Short-Term Pain” to “Long-Term Strategy”
To address the crisis, WACKER launched the PACE program:
-
Annual savings target: approximately €300 million
-
Structural adjustment costs: around €100 million (recorded in Q4 2025)
-
Layoff plan: about 1,500 positions worldwide (~9% of total workforce), mainly in Germany
-
Implementation period: Q1 2026 through the end of 2027
This shows that WACKER’s cost-saving measures are not immediate but part of a long-term, two-year structural adjustment. The changes cover both production and management, reflecting the company’s recognition of a broad decline in competitiveness.
Can This Save the Company? Industry Headwinds Are Hard to Overcome
Demand environment remains weak: In 2025, all four of WACKER’s major business lines declined—silicones, polymers, biosolutions, and polysilicon recorded negative growth. Even semiconductor-grade high-purity silicon, relatively resilient, could not offset the overall downward trend.
This indicates that weakening demand from downstream customers in automotive, construction, and other sectors is permeating the chemical industry. While high-growth areas like semiconductor materials offer some opportunity, the overall business portfolio cannot withstand the general downturn.
Business Segment 2025 Sales Changes:
| Segment | Sales Change |
|---|---|
| Silicones | -7% |
| Polymers | -6% |
| Biosolutions | -4% |
| Polysilicon | -3% |
Energy costs are not a short-term fix: High energy prices in Germany and Europe, along with heavy regulation and taxes, remain a long-term “hard cost” for chemical companies. CEO Hartel publicly called for political reforms, signaling that internal strategic adjustments alone cannot resolve the issue.
Asset write-downs and expanding losses: Of the €800 million annual loss, approximately €600 million came from asset impairments and write-downs, highlighting structural risks in WACKER’s asset portfolio, not just operating costs.
WACKER’s predicament clearly shows the limits of internal adjustments. When an industry enters a structural downturn, fundamental challenges that management cannot control become apparent:
-
Demand is not in the company’s hands. Downstream customers are contracting; layoffs do not generate orders.
-
Costs are not fully controllable. Germany’s “geographic curse”—high energy prices—gives WACKER a structural disadvantage compared to global peers.
-
Scale can become a burden. A heavy asset structure amplifies profit sensitivity during demand drops, causing minor sales declines to trigger massive profit losses.
Thus, WACKER’s restructuring is essentially about “delaying pain” and “buying time.” The broader lesson for the industry is that during a downturn, the goal is not to “reverse the cycle” but to ensure survival until the next cycle. Ultimately, this depends on whether the products retain irreplaceable value in a globally weak demand environment.
2026-08-31
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Wacker Invests 300 Million Euros in New Semiconductor-Grade Polysilicon Production Line in Germany
-
Wacker Chemie Opens Two Tens-of-Millions-of-Euros Production Facilities for Specialty Silicones in Japan and South Korea
-
Hengli Petrochemical’s Dalian Refinery Sanctioned by the U.S.
-
Middle East Conflict Pushes Up Costs as Dow Warns the Chemical Industry Faces a Tougher Period
-
BASF, Covestro, Huntsman Raise MDI Prices in North America Amid Global Supply Crunch
-
BASF's Zhanjiang Plant Steam Cracking Unit Commences Operation
-
$14.5 Billion Solstice–Element Solutions Merger Abruptly Terminated Less Than Two Months After Announcement
-
Hormuz Crisis Exposes India’s Agrochemical “First Mile”
-
Hormuz Crisis Exposes India’s Agrochemical “First Mile”
-
Syngenta Caught in Trade Crossfire
Recommend Reading
-
Unilever Sells Kate Somerville Brand to Rare Beauty Brands
-
Azelis Strengthens Partnership with SI Group, Becoming Its New Distributor of Plastic Additives
-
INEOS Plant Closures Deepen Europe’s Chemical Industry Crisis
-
India Terminates Anti-Dumping Investigation on Chinese Siloxane Polyoxyalkylene Copolymers
-
Wanhua Chemical Announces 2026 Investment Plan: RMB 27.3 Billion for Projects Plus RMB 2.22 Billion for Equity Investments
-
Business Society’s Market Outlook for Petroleum Coke on August 27, 2026: Volatile
-
Business Society’s Market Outlook for Formic Acid on August 19, 2026: Volatile
-
Business Society’s Market Outlook for Fuel Oil 180CST on August 27, 2026: Volatile
-
Business Society’s Market Outlook for Acetic Acid on August 18, 2026: Relatively Strong Performance
-
Business Society’s MTBE Market Outlook on August 27, 2026: Volatile Consolidation
- Hot Searches
- glp-3 retatrutide for sale
- methyl e blue
- 1 4 bdo for sale
- sbr rubber price
- amoxicillin potassium clavulanate info
- bromoethyl benzene
- where can i get retatrutide near me
- light olefins market
- ultra fine ag gypsum soil conditioner
- sodium potassium mag sulfates 17.5 gram-3.13 gram-1.6 gram oral solution
- benzoic acid sds
- fine chemical manufacturing